Cargando…

Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children

BACKGROUND: Levofloxacin is used for treatment and prevention of rifampicin-resistant (RR)-TB in children. Recent data showed higher exposures with 100 mg dispersible compared with non-dispersible tablet formulations with potentially important dosing implications in children. We aimed to verify and...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Laan, Louvina E, Hesseling, Anneke C, Schaaf, H Simon, Palmer, Megan, Draper, Heather R, Wiesner, Lubbe, Denti, Paolo, Garcia-Prats, Anthony J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545503/ https://www.ncbi.nlm.nih.gov/pubmed/37596982 http://dx.doi.org/10.1093/jac/dkad257

Ejemplares similares

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021)

Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
por: Garcia-Prats, Anthony J., et al.
Publicado: (2019)

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018)

Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
por: Chabala, Chishala, et al.
Publicado: (2021)

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial
por: Garcia-Prats, Anthony J., et al.
Publicado: (2022)

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies
por: Ali, Ali Mohamed, et al.
Publicado: (2023)

Population pharmacokinetics of ethambutol in African children: a pooled analysis
por: Tikiso, Tjokosela, et al.
Publicado: (2022)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022)

Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine
por: Andey, Terrick, et al.
Publicado: (2016)

Clofazimine pharmacokinetics in patients with TB: dosing implications
por: Abdelwahab, Mahmoud Tareq, et al.
Publicado: (2020)

Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town
por: Bekker, Adrie, et al.
Publicado: (2016)

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
por: Abdulla, Salim, et al.
Publicado: (2009)

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children
por: Svensson, Elin M., et al.
Publicado: (2018)

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients
por: Setiawan, Eko, et al.
Publicado: (2022)

Optimizing the Formulation for Ginkgolide B Solid Dispersion
por: Wu, Xiao, et al.
Publicado: (2018)

Preparation of Evodiamine Solid Dispersions and Its Pharmacokinetics
por: Xu, H., et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

Urine Colorimetry for Levofloxacin Pharmacokinetics and Personalized Dosing in People with Drug-resistant Tuberculosis
por: Rao, Prakruti, et al.
Publicado: (2020)

Formulation and Evaluation of Levofloxacin and Betamethasone Ophthalmic Emulgel
por: Sabry, Hiba Sabah, et al.
Publicado: (2021)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

High Acceptability of an Orally Dispersible Tablet Formulation by Children
por: Wagner-Hattler, Leonie, et al.
Publicado: (2021)

Synthesis of Lignosulfonate-Based Dispersants for Application in Concrete Formulations
por: Magina, Sandra, et al.
Publicado: (2021)

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders
por: Górniak, Agata, et al.
Publicado: (2023)

Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus(®)
por: Liu, Jinwen, et al.
Publicado: (2015)

Preparation and pharmacokinetics in vivo of linarin solid dispersion and liposome
por: Huang, Yingying, et al.
Publicado: (2022)

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
por: Seddon, James A., et al.
Publicado: (2018)

Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
por: Patil, SA, et al.
Publicado: (2010)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
por: Eisa, Aya M., et al.
Publicado: (2022)

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
por: Gao, Chu-Han, et al.
Publicado: (2014)

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine
por: Sibum, Imco, et al.
Publicado: (2019)

Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
por: Shah, Sanjay, et al.
Publicado: (2012)

Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
por: Koh, P. T., et al.
Publicado: (2013)

Solid Dispersion Formulations by FDM 3D Printing—A Review
por: Khalid, Garba M., et al.
Publicado: (2022)

Formulation and Characterization of Matrine Oil Dispersion to Improve Droplet Wetting and Deposition
por: Li, Meng, et al.
Publicado: (2023)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Pharmacokinetics of five phthalides in volatile oil of Ligusticum sinense Oliv.cv. Chaxiong, and comparison study on physicochemistry and pharmacokinetics after being formulated into solid dispersion and inclusion compound
por: Hu, Peng-yi, et al.
Publicado: (2021)

Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
por: Moultrie, Harry, et al.
Publicado: (2015)

An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
por: Tanner, Lloyd, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sk0ve1gtge5va15jarka34t06a